Senior Scientific, LLC, has established a research collaboration with Weill Cornell Medicine to investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers. Read more
Dean Laurie Glimcher pens a guest piece about the role academic medical centers will have in realizing Vice President Joe Biden's "moonshot to cure cancer" campaign. Read more
A team of researchers led by Himisha Beltran, M.D., discovered the genetic, epigenetic and molecular features that underlie neuroendocrine prostate cancer. Read more
Long a pillar of cancer care, radiation is being used in a new way - to trigger a set of immune responses that converts tumors into internal vaccines. Read more
Manish Shah, M.D., discusses a trial into the use of a STAT3 inhibitor with chemotherapy to curtail stem cell regeneration and reduce recurrence or metastasis in gastric cancer. Read more
Researchers exploring the PI3K pathway have discovered a previously unidentified link between a cancer cell's form and shape and its metabolic capabilities Read more
The Meyer Cancer Center has joined the nation's top cancer centers calling for increased human papillomavirus (HPV) vaccination for the prevention of cancer. Read more
Adding oxaliplatin to fluoropyrimidine-based adjuvant chemotherapy significantly reduces the risk of recurrence of colon cancer, according to Manish Shah, M.D. Read more
Ching-Hsuan Tung, Ph.D., has developed a fluorescent “cancer spray” that can be applied to the ovaries and other organs during surgery to create a luminous outline of cancerous cell clusters. Read more
New prostate cancer treatments could provide hope for those with a rare form of endocrine cancer, according to findings from a team of Meyer researchers led by Thomas Fahey III, M.D. Read more